Epigenetic Control of Regulatory T Cell Stability and Function: Implications for Translation.

Epigenetic Control of Regulatory T Cell Stability and Function: Implications for Translation.
复制标题

DOI:
10.3389/fimmu.2022.861607
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
Singer BD
Singer BD
中科院分区:
医学2区
文献类型:
--
作者:
Joudi AM;Reyes Flores CP;Singer BD

文献摘要

参考文献

被引文献

相似文献

FoxP3+调节性T(Treg)细胞维持免疫稳态,促进自身耐受,并在解决急性炎症,提供组织保护和修复组织损伤中发挥新兴作用。一些数据表明,FoxP3+ T细胞是可塑性的,表现出在富含炎性嘌呤的微环境中失去功能的易感性,并矛盾地导致炎症病理学。因此,可塑性可能是Treg细胞免疫治疗的障碍。在这里,我们讨论了围绕Treg细胞可塑性的争议,并探讨了炎症微环境中Treg细胞稳定性的决定因素,重点是临床方案可以利用的表观遗传机制,以提高疗效并限制基于Treg细胞的治疗的毒性。
FoxP3+ regulatory T (Treg) cells maintain immune homeostasis, promote self-tolerance, and have an emerging role in resolving acute inflammation, providing tissue protection, and repairing tissue damage. Some data suggest that FoxP3+ T cells are plastic, exhibiting susceptibility to losing their function in inflammatory cytokine-rich microenvironments and paradoxically contributing to inflammatory pathology. As a result, plasticity may represent a barrier to Treg cell immunotherapy. Here, we discuss controversies surrounding Treg cell plasticity and explore determinants of Treg cell stability in inflammatory microenvironments, focusing on epigenetic mechanisms that clinical protocols could leverage to enhance efficacy and limit toxicity of Treg cell-based therapeutics.
DOI: 10.1016/j.immuni.2007.09.010
发表时间: 2007-11-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Hill, Jonathan A.;Feuerer, Markus;Benoist, Christophe
通讯作者: Benoist, Christophe
低剂量地西他滨可调节 T 细胞稳态并恢复免疫性血小板减少症的免疫耐受。
DOI: 10.1182/blood.2020008477
发表时间: 2021-08-26
期刊: Blood
影响因子: 20.3
作者:
Han P;Hou Y;Zhao Y;Liu Y;Yu T;Sun Y;Wang H;Xu P;Li G;Sun T;Hu X;Liu X;Li L;Peng J;Zhou H;Hou M
通讯作者: Hou M
DOI: 10.1038/s41588-020-0618-1
发表时间: 2020-06
期刊: Nature genetics
影响因子: 30.8
作者:
Douillet D;Sze CC;Ryan C;Piunti A;Shah AP;Ugarenko M;Marshall SA;Rendleman EJ;Zha D;Helmin KA;Zhao Z;Cao K;Morgan MA;Singer BD;Bartom ET;Smith ER;Shilatifard A
通讯作者: Shilatifard A
DOI: 10.1016/j.omtm.2018.01.006
发表时间: 2018-03-16
期刊: Molecular therapy. Methods & clinical development
影响因子: --
作者:
Fraser H;Safinia N;Grageda N;Thirkell S;Lowe K;Fry LJ;Scottá C;Hope A;Fisher C;Hilton R;Game D;Harden P;Bushell A;Wood K;Lechler RI;Lombardi G
通讯作者: Lombardi G
DOI: 10.2119/molmed.2013.00159
发表时间: 2014-01-01
期刊: MOLECULAR MEDICINE
影响因子: 5.7
作者:
Chan, Michael W. Y.;Chang, Chia-Bin;Wu, Shu-Fen
通讯作者: Wu, Shu-Fen